{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:23:13Z","timestamp":1793733793733,"version":"4.6.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Oral squamous cell carcinoma (OSCC) is the most invasive oral malignancy in adults and is associated with a poor prognosis. Accurate prognostic models are urgently needed, however, knowledge of the probable mechanisms behind OSCC tumorigenesis and prognosis remain limited. The clinical importance of the interplay between the immune system and tumor microenvironment has become increasingly evident. This study explored immune-related alterations at the multi-omics level to extract accurate prognostic markers linked to the immune response and presents a more accurate landscape of the immune genomic map during OSCC. The Cancer Genome Atlas (TCGA) OSCC cohort (n = 329) was used to detect the immune infiltration pattern of OSCC and categorize patients into two immunity groups using single-sample gene set enrichment analysis (ssGSEA) and hierarchical clustering analysis. Multiple strategies, including lasso regression (LASSO), Cox proportional hazards regression, and principal component analysis (PCA) were used to screen clinically significant signatures and identify an incorporated prognosis model with robust discriminative power on the survival status of both the training and testing set. We identified two OSCC subtypes based on immunological characteristics: Immunity-high and immunity low, and verified that the categorization was accurate and repeatable. Immunity_ high cluster with a higher immunological and stromal score. 1047 differential genes (DEGs) integrate with immune genes to obtain 319 immue-related DEGs. A robust model with five signatures for OSCC patient prognosis was established. The GEO cohort (n = 97) were used to validate the risk model\u2019s predictive value. The low-risk group had a better overall survival (OS) than the high-risk group. Significant prognostic potential for OSCC patients was found using ROC analysis and immune checkpoint gene expression was lower in the low-risk group. We also investigated at the therapeutic sensitivity of a number of frequently used chemotherapeutic drugs in patients with various risk factors. The underlying biological behavior of the OSCC cell line was preliminarily validated. This study characterizes a reliable marker of OSCC disease progression and provides a new potential target for immunotherapy against this disease.<\/jats:p>","DOI":"10.3389\/fimmu.2022.922195","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:05:29Z","timestamp":1657127129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":90,"title":["A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31146-8","article-title":"Oral Diseases: A Global Public Health Challenge","volume":"394","author":"Peres","year":"2019","journal-title":"Lancet (Lond Engl)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01054","article-title":"Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma","volume":"9","author":"Huang","year":"2019","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human Papillomavirus and Survival of Patients With Oropharyngeal Cancer","volume":"363","author":"Ang","year":"2010","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.558596","article-title":"Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma","volume":"10","author":"Hou","year":"2020","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103333","article-title":"M6A-Related Bioinformatics Analysis Reveals That HNRNPC Facilitates Progression of OSCC via EMT","volume":"12","author":"Huang","year":"2020","journal-title":"Aging"},{"key":"B7","article-title":"Expression Profiles Analysis Identifies a Novel three-mRNA Signature to Predict Overall Survival in Oral Squamous Cell Carcinoma","volume":"8","author":"Zhao","year":"2018","journal-title":"Am J Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29210","article-title":"Identification of a Six-Gene Prognostic Signature for Oral Squamous Cell Carcinoma","volume":"235","author":"Wang","year":"2020","journal-title":"J Cell Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","article-title":"The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Squamous Cell Carcinoma of the Head and Neck (HNSCC)","volume":"7","author":"Cohen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to Treat Immune Hot, Altered and Cold Tumours With Combination Immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the Tumor Microenvironment: Removing Obstruction to Anticancer Immune Responses and Immunotherapy","volume":"27","author":"Pitt","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the Tumor Immune Microenvironment (TIME) for Effective Therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0409-6","article-title":"Tissue-Infiltrating Immune Cells as Prognostic Markers in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis","volume":"120","author":"Hadler-Olsen","year":"2019","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and Neck Squamous Cell Carcinoma: Genomics and Emerging Biomarkers for Immunomodulatory Cancer Treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2015.10.009","article-title":"Immunotherapy and Tumor Microenvironment","volume":"370","author":"Tang","year":"2016","journal-title":"Cancer Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4085","article-title":"The Immune Subtypes and Landscape of Squamous Cell Carcinoma","volume":"25","author":"Li","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e001048","DOI":"10.1136\/jitc-2020-001048","article-title":"Malignant Cell-Specific CXCL14 Promotes Tumor Lymphocyte Infiltration in Oral Cavity Squamous Cell Carcinoma","volume":"8","author":"Parikh","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.607622","article-title":"Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma","volume":"10","author":"Xiao","year":"2020","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"107162","DOI":"10.1016\/j.intimp.2020.107162","article-title":"Analysis of Immune Subtypes Based on Immunogenomic Profiling Identifies Prognostic Signature for Cutaneous Melanoma","volume":"89","author":"Hu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","article-title":"Prrophetic: An R Package for Prediction of Clinical Chemotherapeutic Response From Tumor Gene Expression Levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15753","article-title":"Endoplasmic Reticulum Stress Remodels Alveolar Bone Formation After Tooth Extraction","volume":"24","author":"Chen","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7150\/thno.53649","article-title":"Siglec15 Shapes a non-Inflamed Tumor Microenvironment and Predicts the Molecular Subtype in Bladder Cancer","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5286251","DOI":"10.1155\/2022\/5286251","article-title":"Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma","volume":"2022","author":"Lv","year":"2022","journal-title":"J Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01806-5","article-title":"A Seven-Gene Signature to Predict the Prognosis of Oral Squamous Cell Carcinoma","volume":"40","author":"Ribeiro","year":"2021","journal-title":"Oncogene"},{"key":"B26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12903-021-01587-z","article-title":"A Four-Hypoxia-Genes-Based Prognostic Signature for Oral Squamous Cell Carcinoma","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Oral Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6657767","DOI":"10.1155\/2021\/6657767","article-title":"Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics","volume":"2021","author":"Zhang","year":"2021","journal-title":"BioMed Res Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.07.058","article-title":"Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity","volume":"24","author":"Campbell","year":"2018","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"105038","DOI":"10.1016\/j.oraloncology.2020.105038","article-title":"Tumor Microenvironment and Oral Squamous Cell Carcinoma: A Crosstalk Between the Inflammatory State and Tumor Cell Migration","volume":"112","author":"Alves","year":"2021","journal-title":"Oral Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.2955","article-title":"Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial","volume":"6","author":"Schoenfeld","year":"2020","journal-title":"JAMA Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1938890","DOI":"10.1080\/2162402X.2021.1938890","article-title":"YKT6, as a Potential Predictor of Prognosis and Immunotherapy Response for Oral Squamous Cell Carcinoma, is Related to Cell Invasion, Metastasis, and CD8+ T Cell Infiltration","volume":"10","author":"Yang","year":"2021","journal-title":"Oncoimmunology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e002434","DOI":"10.1136\/jitc-2021-002434","article-title":"Immune Landscape and Subtypes in Primary Resectable Oral Squamous Cell Carcinoma: Prognostic Significance and Predictive of Therapeutic Response","volume":"9","author":"Diao","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.2214","article-title":"Genomics- and Transcriptomics-Based Patient Selection for Cancer Treatment With Immune Checkpoint Inhibitors: A Review","volume":"2","author":"Dijkstra","year":"2016","journal-title":"JAMA Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103369","article-title":"Identification of an Immune-Related Long non-Coding RNA Signature and Nomogram as Prognostic Target for Muscle-Invasive Bladder Cancer","volume":"12","author":"Song","year":"2020","journal-title":"Aging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.3390\/ijms22158236","article-title":"Effects of Cancer Presence and Therapy on the Platelet Proteome","volume":"22","author":"Walraven","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13286","article-title":"Insulin-Like Growth Factor-1 Signaling is Responsible for Cathepsin G-Induced Aggregation of Breast Cancer MCF-7 Cells","volume":"108","author":"Morimoto-Kamata","year":"2017","journal-title":"Cancer Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-09-0028","article-title":"Cathepsin G-Mediated Activation of Pro-Matrix Metalloproteinase 9 at the Tumor-Bone Interface Promotes Transforming Growth Factor-Beta Signaling and Bone Destruction","volume":"7","author":"Wilson","year":"2009","journal-title":"Mol Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.204","article-title":"AML1-ETO Targets and Suppresses Cathepsin G, a Serine Protease, Which is Able to Degrade AML1-ETO in T(8;21) Acute Myeloid Leukemia","volume":"32","author":"Jin","year":"2013","journal-title":"Oncogene"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6203759","DOI":"10.1155\/2021\/6203759","article-title":"Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma","volume":"2021","author":"Zou","year":"2021","journal-title":"J Immunol Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S293148","article-title":"Bioinformatics Analyses Indicate That Cathepsin G (CTSG) Is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC)","volume":"14","author":"Huang","year":"2021","journal-title":"Onco Targets Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/13543776.2021.1825688","article-title":"OX40 Agonists for Cancer Treatment: A Patent Review","volume":"31","author":"Cebada","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/cancers13061230","article-title":"Single-Cell Deconvolution of Head and Neck Squamous Cell Carcinoma","volume":"13","author":"Qi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02249","article-title":"Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire","volume":"9","author":"Collins","year":"2018","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S351831","article-title":"And Hypoxia Combined Gene Signature Predicts the Prognosis and Affects Immune Infiltration of Patients With Colon Cancer","volume":"15","author":"Mao","year":"2022","journal-title":"Int J Gen Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S246289","article-title":"miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting Stc2","volume":"13","author":"Ma","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1271-1","article-title":"STC2: A Predictive Marker for Lymph Node Metastasis in Esophageal Squamous-Cell Carcinoma","volume":"18","author":"Kita","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i42.4738","article-title":"CXC Family of Chemokines as Prognostic or Predictive Biomarkers and Possible Drug Targets in Colorectal Cancer","volume":"24","author":"Cabrero-de Las Heras","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170277","article-title":"CCL22 Controls Immunity by Promoting Regulatory T Cell Communication With Dendritic Cells in Lymph Nodes","volume":"216","author":"Rapp","year":"2019","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3499","article-title":"Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression","volume":"75","author":"Anz","year":"2015","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/cancers13030571","article-title":"The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses","volume":"13","author":"Heeran","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e39479","DOI":"10.7554\/eLife.39479","article-title":"miR-34a Is a microRNA Safeguard for Citrobacter-Induced Inflammatory Colon Oncogenesis","volume":"7","author":"Wang","year":"2018","journal-title":"Elife"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.922195\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T14:54:54Z","timestamp":1658415294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.922195\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2022.922195"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.922195","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"922195"}}